Chicago-based CTRL Therapeutics, a biotech company developing a cell therapy platform for solid tumors, today announced a $10 million seed financing led by Gene 11 April 2023
The National Institute for Health and Care Excellence (NICE) has issued preliminary guidance which does not recommend Cabometyx (cabozantinib) for a specific us 5 April 2023
BioSenic, a Belgian biotech company specializing in serious autoimmune and inflammatory diseases and cell repair, has named Lieven Huysse, as permanent chief me 3 April 2023
Gaetan Leblay has been named vice president, customer and digital strategy for Europe, the Middle East and Africa at the Johnson & Johnson subsidiary Janssen. 30 March 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.